Notice of Application - 2011
[Federal Register Volume 76, Number 128 (Tuesday, July 5, 2011)]
[Notices]
[Page 39126]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16793]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 4, 2011, Chemtos,
LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
| Drug |
Schedule |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lisdexamfetamine (1205) |
II |
| Methylphenidate (1724) |
II |
| Nabilone (7379) |
II |
| Phenylacetone (8501) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Etorphine HCL (9059) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Ecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Meperidine-intermediate-A (9232) |
II |
| Meperidine-intermediate-B (9233) |
II |
| Meperidine-intermediate-C (9234) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Dihydroetorphine (9334) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Racemethorphan (9732) |
II |
| Racemorphan (9733) |
II |
The company plans to manufacture small quantities of the listed
controlled substances in bulk for distribution to its customers for use
as reference standards.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than September 6, 2011.
Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-16793 Filed 7-1-11; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
